James Evans is the co-chair of the securities and corporate finance group and focuses his practice on corporate and securities law, representing technology and life sciences companies of international prominence in a wide range of corporate matters. He has extensive experience in capital markets transactions and has represented issuers, underwriters and other parties in a variety of public and private offerings of both equity and debt securities, including some of the most high-profile technology public offerings in history. Jamie has led or co-led offerings that have raised over $30 billion of aggregate proceeds. In addition, Jamie regularly advises on mergers and acquisitions and related securities law issues and provides ongoing advice to both public and private companies on general corporate compliance, SEC reporting and governance issues.
Jamie is active in the Seattle and Silicon Valley business communities, regularly speaking on corporate finance topics, including initial public offerings, other corporate finance and capital formation issues and SEC regulation. He was recognized as a Washington "Super Lawyer" in the area of Securities & Corporate Finance for 2016-2017, and was also named a "Rising Star" in 2012. In 2014, Jamie was named among the top attorneys in the United States under the age of 40 by Law360.
In both 2016 and 2017, Jamie has been highlighted by Legal 500 as among the leading lawyers in technology transactions and U.S. capital markets. The firm as a whole has ranked in Tier 1 of Legal 500 's technology transactions and venture capital and emerging companies categories for the past two years. Fenwick & West is also recognized as a leading law firm for capital markets work.
Jamie began his career at Simpson Thacher & Bartlett LLP where he focused primarily on public offerings and mergers and acquisitions.
Representative initial public offerings have included:
Representative other capital markets transactions have included: